AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nabriva Therapeutics plc

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
323
AVG Volume
53
Trailing/Forward PE
-0/0
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
010M20M30M40M21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
23 Q229.39M
23 Q135.59M
22 Q435.67M
22 Q334.14M
22 Q233.78M
22 Q132.75M
21 Q427.22M
21 Q320.34M
21 Q212.49M
21 Q14.7M
Net Income (USD) · TTM
-80M-60M-40M-20M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
23 Q2-55.05M
23 Q1-54.07M
22 Q4-57.19M
22 Q3-47.47M
22 Q2-46.61M
22 Q1-47.29M
21 Q4-49.45M
21 Q3-54.22M
21 Q2-56.52M
21 Q1-60.21M
Operating Income (USD) · TTM
-60M-40M-20M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
23 Q2-54.03M
23 Q1-52.41M
22 Q4-55.49M
22 Q3-46.04M
22 Q2-45.66M
22 Q1-46.64M
21 Q4-48.53M
21 Q3-53.91M
21 Q2-56.31M
21 Q1-59.39M
EBITDA (USD) · TTM
-60M-40M-20M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
23 Q2-53.61M
23 Q1-51.92M
22 Q4-54.61M
22 Q3-45.58M
22 Q2-45.37M
22 Q1-45.76M
21 Q4-47.89M
21 Q3-52.06M
21 Q2-54.03M
21 Q1-58.13M
Cash Flows (USD) · TTM
-80M-60M-40M-20M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q2-13.02M
23 Q1-26.64M
22 Q4-36.92M
22 Q3-41.41M
22 Q2-48.37M
22 Q1-53.74M
21 Q4-59.58M
21 Q3-66.84M
21 Q2-66.2M
21 Q1-65.01M
EPS (USD) · TTM
-100-75-50-25021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
23 Q2-17.98
23 Q1-18.63
22 Q4-20.94
22 Q3-19.51
22 Q2-20.57
22 Q1-23.43
21 Q4-31.63
21 Q3-53.49
21 Q2-70.72
21 Q1-97.71
Expenses (USD) · TTM
-20M020M40M60M80MR&DSG&ACapex21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q245.11M
23 Q155.12M
22 Q459.74M
22 Q364.38M
22 Q263.81M
22 Q164.52M
21 Q464.3M
21 Q370.22M
21 Q269.23M
21 Q167.92M
Shares Outstanding · TTM
-2M-1.5M-1M-500K021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
23 Q2-1.73M
23 Q1-1.63M
22 Q4-633K
22 Q3-498K
22 Q20
22 Q10
21 Q40
21 Q30
21 Q20
21 Q10
Employee Count
05010015020020152016201720182019202020212022
NBRVF Employee Count by quarter
PeriodEmployee Count
202239
202173
202072
2019162
2018110
201788
201659
201552
Free Cash Flow Yield
-600000000%-400000000%-200000000%0%med -4030950.29%Jan 25May 25Sep 25Jan 26May 26Sep 26
NBRVF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-4030950.29%
Sep 26-4030950.29%
Aug 26-4030950.29%
Aug 26-4030950.29%
Aug 26-4030950.29%
Aug 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jun 26-4030950.29%
Jun 26-4030950.29%
Jun 26-4030950.29%
Jun 26-4030950.29%
May 26-4030950.29%
May 26-4030950.29%
May 26-4030950.17%
May 26-2015475.14%
May 26-2015475.14%
Apr 26-2015475.14%
Apr 26-2015475.14%
Apr 26-2015475.14%
Apr 26-2015475.14%
Mar 26-2015475.14%
Mar 26-2015475.14%
Mar 26-2015475.14%
Mar 26-2015475.14%
Feb 26-2015475.09%
Feb 26-2015475.14%
Feb 26-2015475.14%
Feb 26-2015475.14%
Jan 26-4030950.29%
Jan 26-4030950.29%
Jan 26-4030950.17%
Jan 26-4030950.17%
Jan 26-4030950.29%
Dec 25-4030950.29%
Dec 25-4030950.29%
Dec 25-4030950.17%
Dec 25-4030950.29%
Nov 25-4030950.29%
Nov 25-403095017.02%
Nov 25-4030950.29%
Nov 25-4030950.17%
Oct 25-4030950.29%
Oct 25-4030950.17%
Oct 25-4030950.29%
Oct 25-4030950.17%
Oct 25-4030950.29%
Sep 25-4030950.17%
Sep 25-4030950.29%
Sep 25-4030950.29%
Sep 25-4030950.29%
Aug 25-4030950.29%
Aug 25-4030950.29%
Aug 25-4030950.29%
Aug 25-4030950.17%
Aug 25-4030950.29%
Jul 25-4030950.29%
Jul 25-4030950.29%
Jul 25-4030950.17%
Jul 25-4030950.29%
Jun 25-4030950.29%
Jun 25-4030950.17%
Jun 25-4030950.17%
Jun 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
Apr 25-4030950.17%
Apr 25-4030950.29%
Apr 25-4030950.29%
Apr 25-4030950.29%
Mar 25-4030950.29%
Mar 25-4030950.29%
Mar 25-403095017.02%
Mar 25-4030950.29%
Feb 25-4030950.29%
Feb 25-4030950.29%
Feb 25-403095017.02%
Feb 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Dec 24-403095017.02%
Dec 24-4030950.29%
Dec 24-403095017.02%
Dec 24-4030950.29%
Nov 24-4030950.17%
Nov 24-403095017.02%
Nov 24-4030950.29%
Nov 24-2015475.14%
Nov 24-1343649.99%
Oct 24-2015475.09%
Oct 24-2015475.09%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NBRVF Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Price to Book
00.511.52med 0.34Aug 21Dec 21Mar 22Jul 22Oct 22Feb 23May 23
NBRVF Price to Book by quarter
PeriodPrice to Book
May 231.84
May 231.62
May 231.62
Apr 231.51
Apr 231.57
Apr 230.16
Apr 230.19
Mar 230.19
Mar 230.19
Mar 230.17
Mar 230.17
Mar 230.18
Feb 230.19
Feb 230.19
Feb 230.2
Feb 230.2
Jan 230.16
Jan 230.17
Jan 230.16
Jan 230.14
Dec 220.2
Dec 220.2
Dec 220.2
Dec 220.21
Dec 220.23
Nov 220.23
Nov 220.24
Nov 220.25
Nov 220.16
Oct 220.18
Oct 220.17
Oct 220.17
Oct 220.19
Sep 220.15
Sep 220.17
Sep 220.28
Sep 220.3
Sep 220.3
Aug 220.31
Aug 220.33
Aug 220.36
Aug 220.34
Jul 220.24
Jul 220.23
Jul 220.25
Jul 220.28
Jul 220.24
Jun 220.26
Jun 220.24
Jun 220.28
Jun 220.27
May 220.26
May 220.25
May 220.3
May 220.34
Apr 220.33
Apr 220.34
Apr 220.38
Apr 220.41
Apr 220.43
Mar 220.38
Mar 220.35
Mar 220.34
Mar 220.34
Feb 220.37
Feb 220.41
Feb 220.39
Feb 220.38
Jan 220.36
Jan 220.37
Jan 220.43
Jan 220.47
Dec 210.48
Dec 210.49
Dec 210.53
Dec 210.54
Dec 210.56
Nov 210.67
Nov 210.73
Nov 210.82
Nov 210.78
Oct 210.67
Oct 210.64
Oct 210.69
Oct 210.65
Oct 210.7
Sep 210.69
Sep 210.67
Sep 210.66
Sep 210.65
Aug 210.62
Aug 210.6
Aug 210.61
Aug 210.69
Jul 210.53
Jul 210.54
Jul 210.54
Jul 210.58
Jul 210.62
Jun 210.68
Nabriva Therapeutics plc
NBRVF
Stockpicker

Video analysis: NBRVF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.